Cargando…
Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine
Prophylactic therapy of Ménière's disease (MD) includes betahistine and calcium-blockers (the latter also useful for migraine prevention). The aim of our work was to assess the efficacy of combined therapy with cinnarizine and betahistine in MD subjects both with and without migraine and poorly...
Autores principales: | Teggi, R., Gatti, O., Sykopetrites, V., Quaglieri, S., Benazzo, M., Bussi, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SpA
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299158/ https://www.ncbi.nlm.nih.gov/pubmed/25709150 |
Ejemplares similares
-
Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience
por: Monzani, D., et al.
Publicado: (2012) -
Point prevalence of vertigo and dizziness in a sample of 2672 subjects and correlation with headaches
por: Teggi, R., et al.
Publicado: (2016) -
Evaluation of a large cohort of adult patients with Ménière’s disease: bedside and clinical history
por: Teggi, Roberto, et al.
Publicado: (2021) -
Report from a Consensus Conference on the treatment of Ménière’s disease with betahistine: rationale, methodology and results
por: CASANI, A.P., et al.
Publicado: (2018) -
Evolution of migraine vertigo in overlapping syndrome with Ménière’s disease: prognostic role of instrumental examination
por: Dispenza, Francesco, et al.
Publicado: (2021)